ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Effect of Gut Microbiota on the Pharmacokinetics of Nifedipine in Spontaneously Hypertensive Rats

Zhou, Rong; Yang, Haijun; Zhu, Peng; Liu, Yujie; Zhang, Yanjuan; Zhang, Wei; Zhou, Honghao; Li, Xiong*; Li, Qing*广东药学院; 1
Pharmaceutics2023-8DOI: 10.3390/pharmaceutics15082085
13阅读
引用收藏
分享

摘要

The pharmacokinetic variability of nifedipine widely observed in the clinic cannot be fully explained by pharmacogenomics. As a new factor affecting drug metabolism, how the gut microbiota affects the pharmacokinetics of nifedipine needs to be explored. Spontaneously hypertensive rats (SHRs) have been commonly used in hypertension-related research and served as the experimental groups; Wistar rats were used as control groups. In this study, the bioavailability of nifedipine decreased by 18.62% (p < 0.05) in the SHRs compared with the Wistar rats. Changes in microbiota were associated with the difference in pharmacokinetics. The relative abundance of Bacteroides dorei was negatively correlated with AUC(0-t) (r = -0.881, p = 0.004) and C-max (r = -0.714, p = 0.047). Analysis of serum bile acid (BA) profiles indicated that glycoursodeoxycholic acid (GUDCA) and glycochenodeoxycholic acid (GCDCA) were significantly increased in the SHRs. Compared with the Wistar rats, the expressions of CYP3A1 and PXR were upregulated and the enzyme activity of CYP3A1 increased in the SHRs. Spearman's rank correlation revealed that Bacteroides stercoris was negatively correlated with GUDCA (r = -0.7126, p = 0.0264) and GCDCA (r = -0.6878, p = 0.0339). Moreover, GUDCA was negatively correlated with C-max (r = -0.556, p = 0.025). In primary rat hepatocytes, GUDCA could induce the expressions of PXR target genes CYP3A1 and Mdr1a. Furthermore, antibiotic treatments in SHRs verified the impact of microbiota on the pharmacokinetics of nifedipine. Generally, gut microbiota affects the pharmacokinetics of nifedipine through microbial biotransformation or by regulating the enzyme activity of CYP3A1.

学科与关键词

关键词
gut microbiotanifedipinepharmacokineticsSHR
相关
加载中…
  • Antibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe DrugsS
    Yang, Haijun; Zhang, Yanjuan; Zhou, Rong; Wu, Tianyuan; Zhu, Peng; Liu, Yujie; Zhou, Jian; Xiong, Yalan; Xiong, Yanling; Zhou, Honghao; Zhang, Wei; Shu, Yan; Li, Xiong; Li, QingDrug Metabolism and Disposition, 2023, 51(4): 509-520.被引 2
  • Effects of berberine on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism
    Li Hong; Liu Lu; Xie Lei; Gan Dongmei; Jiang XiaoqingPharmaceutical Biology, 2016, 54(12): 2886-2894.
  • Berberine Improves Vascular Dysfunction by Inhibiting Trimethylamine-N-oxide via Regulating the Gut Microbiota in Angiotensin II-Induced Hypertensive Mice
    Wang, Zhichao; Wu, Fang; Zhou, Qianbing; Qiu, Yumin; Zhang, Jianning; Tu, Qiang; Zhou, Zhe; Shao, Yijia; Xu, Shiyue*; Wang, Yan*; Tao, Jun*Frontiers in Microbiology, 2022, 13: 814855.被引 12
查看全部 →

发表信息

论文状态
公开发表
期刊
Pharmaceutics
发表日期
2023-08
卷期
第 15 卷, 第 8 期
页码
2085
DOI
10.3390/pharmaceutics15082085
成果收录
SCIE
资助标注
We thank Yicheng Wang, Li Li, Kang He, and Yilei Peng for the UPLC MS/MS technique; Jian Zhou for primary hepatocyte isolation; Yalan Xiong and Yanling Xiong for experimental assistance; Tianyuan Wu and Yusheng Wang for literature assistance; and Dingsheng

作者

  • Z

    Zhou, Rong (第一作者)

  • Y

    Yang, Haijun

查看全部 9 位作者收起作者
  • Z

    Zhu, Peng

  • L

    Liu, Yujie

  • Z

    Zhang, Yanjuan

  • Z

    Zhang, Wei

  • Z

    Zhou, Honghao

  • L

    Li, Xiong (通讯)

    1 · guangdong pharmaceut univ

  • L

    Li, Qing (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417